Moderna to supply 20 mln doses of COVID-19 vaccine to Peru
The Peninsula
U.S. drugmaker Moderna Inc will supply 20 million doses of its COVID-19 vaccine to Peru, with deliveries starting in the first quarter of 2022.
Moderna said on Friday it will work with the regulators in the country to pursue necessary approvals prior to distribution of its vaccine, which is not currently approved for use in Peru.
The country has so far vaccinated about 37.6% of its population, according to the latest Reuters tally.
More Related News